PHARMATAZ 45mg orodispersible tablets ACTAVIS
Active substance: mirtazapine
N06AX11 Nervous system | Antidepressants | Other antidepressants
Indicated for: depression
Find medicines for human use by name or active substance.
Browse by initial
581–600 of 1,444 medicines
Active substance: mirtazapine
N06AX11 Nervous system | Antidepressants | Other antidepressants
Indicated for: depression
Active substance: benzalkonium chloride
Indicated for: local antisepsis
Active substance: benzalkonium chloride
Indicated for: local antisepsis
Active substance: benzalkonium chloride
Indicated for: local antisepsis
Active substance: benzalkonium chloride
Indicated for: local antisepsis
Active substance: Panax ginseng + vitamins + minerals
Indicated for: asthenia; fatigue; vitamin and mineral deficiency
Active substance: phenytoin
N03AB02 Nervous system | Antiepileptics | Antiepileptics | Hydantoin derivatives
Indicated for: epilepsy
Active substance: phenytoin
N03AB02 Nervous system | Antiepileptics | Antiepileptics | Hydantoin derivatives
Indicated for: epilepsy
Active substance: phenylephrine
Indicated for: nasal congestion; rhinitis
Active substance: phenytoin
N03AB02 Nervous system | Antiepileptics | Antiepileptics | Hydantoin derivatives
Indicated for: epilepsy
Active substance: pertuzumab + trastuzumab
Indicated for: breast cancer
Active substance: pertuzumab + trastuzumab
Indicated for: breast cancer
Active substance: diosmin
C05CA03 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
Indicated for: chronic venous insufficiency; capillary fragility
Active substance: rutoside + bromelain + trypsin
Indicated for: inflammation; post-traumatic edema
Active substance: porfimer
Indicated for: photodynamic therapy
Active substance: porfimer
Indicated for: photodynamic therapy
Active substance: combinations
B05ZB Blood and blood forming organs | Hemodialytics and hemofiltrates | Hemofiltrates
Indicated for: various therapeutic indications
Active substance: gefitinib
Indicated for: non-small cell lung cancer
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.